Evolution of the Average Target: Arkema

Evolution of the Average Target - Arkema

Evolution of the Target Price: Arkema

Evolution of the Target Price - Arkema

Changes in Analyst Recommendations: Arkema

1ab70fb.5hTwHymytHAil7r5b_FLkGhv3W3loamP_NOdR6aQVX0.jn6gbxjm0y9074qmMIQy_hArrgi3jMbApIf3IuKoChCOIpF5at3DGnTa6w~c250766edcfe77153aa3e3536fa8d422
05/11 Arkema: Arkema sails on strong pricing through inflation storm Alphavalue
07/10 EU contemplates changes to agri-chemical regulations Alphavalue
02/10 Arkema attempts to end seven-session losing streak Zonebourse
17/09 AlphaValue/Baader Europe Upgrades Arkema to Add, Trims PT MT
12/08 Barclays Upgrades Arkema to Equalweight, Raises PT MT
30/07 Arkema: A strong Q2 but limited visibility for H2 Alphavalue
09/07 AlphaValue/Baader Europe Downgrades Arkema to Add, Cuts PT MT
09/07 Arkema: More cautious on demand and pricing Alphavalue
30/06 AlphaValue/Baader Europe Upgrades Arkema to Buy, Lifts PT MT
26/06 On Field Investment Research Downgrades Arkema to Neutral, Cuts PT MT
23/06 Deutsche Bank Raises Its Price Target on Arkema Zonebourse
08/06 Goldman Sachs Downgrades Arkema to Neutral, Lowers PT MT
08/06 Arkema retreats following Goldman Sachs downgrade Zonebourse
22/05 Analyst Ratings France: JP Morgan turns bearish on Arkema, HSBC raises Nexans target Zonebourse
07/05 Kepler Cheuvreux Downgrades Arkema to Reduce MT
06/05 Arkema: Key upstream solutions defend broader softness Alphavalue
04/05 Arkema holds firm despite AlphaValue downgrade Zonebourse
04/05 Arkema: A more conservative stance Alphavalue
20/04 Bernstein Upgrades Arkema to Market Perform, Boosts PT MT
20/04 Berenberg downgrades Arkema to Hold following recent share price rally Zonebourse
20/04 Arkema Downgraded to Hold as Berenberg Warns 'Good Times May Not Stick' MT
09/04 Arkema unmoved by Deutsche Bank note Zonebourse
27/03 Evonik hits annual high following Morgan Stanley upgrade DP
17/03 Sulfur and methanol prices soar on Middle East conflict Alphavalue
05/03 Berenberg Cuts Arkema EPS Projections After 'Tough' Q4 2025; Price Target Up MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+9.14%
+7.77%
-9.49%
+8.18%
-5.29%
+11.31%
+20%
-6.83%
+11.17%
+41.78%
Average +8.77%
Weighted average by Cap. +6.13%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
57.85EUR
Average target price
62.54EUR
Spread / Average Target
+8.10%
High Price Target
80.00EUR
Spread / Highest target
+38.29%
Low Price Target
50.00EUR
Spread / Lowest Target
-13.57%

Analyst Consensus Detail

Analyst consensus - Arkema

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Arkema
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Arkema